{"entity":{"type":"insider","cik":"0001392266","url":"/insider/0001392266","json_url":"/insider/0001392266.json","name":"Berkman Charles S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":48,"n_filings":29,"first":"2011-02-18","last":"2026-04-07","span_basis":"filed_date"},"name_variants":[{"name":"Berkman Charles S","source":"filing","n_filings":29,"first_seen":"2011-02-18","last_seen":"2026-04-07"}],"transactions":[{"id":6023837,"accession":"0001628280-26-024131","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-024131","line_url":"/filing/0001628280-26-024131#line-2","is_derivative":false,"issuer_cik":"0001392266","issuer_name":"OmniAb, Inc.","issuer_ticker":"OABI","issuer_name_source":null,"issuer_url":"/issuer/0001392266","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7157.0,"shares_display":"7,157","price_per_share":1.49,"price_display":"1.49","price_state":"stated","total_value":10663.93,"total_display":"10,663.93","total_whole":"10,664","shares_owned_after":399085.0,"shares_owned_after_display":"399,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-07","filed_date":"2026-04-07","scope":"insider"},{"id":5777139,"accession":"0001392266-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001392266-26-000002","line_url":"/filing/0001392266-26-000002#line-2","is_derivative":false,"issuer_cik":"0001392266","issuer_name":"OmniAb, Inc.","issuer_ticker":"OABI","issuer_name_source":null,"issuer_url":"/issuer/0001392266","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9673.0,"shares_display":"9,673","price_per_share":1.71,"price_display":"1.71","price_state":"stated","total_value":16540.83,"total_display":"16,540.83","total_whole":"16,541","shares_owned_after":392700.0,"shares_owned_after_display":"392,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-18","scope":"insider"},{"id":5814193,"accession":"0001628280-26-008704","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-008704","line_url":"/filing/0001628280-26-008704#line-2","is_derivative":false,"issuer_cik":"0001392266","issuer_name":"OmniAb, Inc.","issuer_ticker":"OABI","issuer_name_source":null,"issuer_url":"/issuer/0001392266","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6990.0,"shares_display":"6,990","price_per_share":1.7,"price_display":"1.70","price_state":"stated","total_value":11883.0,"total_display":"11,883.00","total_whole":"11,883","shares_owned_after":383623.0,"shares_owned_after_display":"383,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-17","scope":"insider"},{"id":4050098,"accession":"0001392266-25-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001392266-25-000006","line_url":"/filing/0001392266-25-000006#line-2","is_derivative":false,"issuer_cik":"0001392266","issuer_name":"OmniAb, Inc.","issuer_ticker":"OABI","issuer_name_source":null,"issuer_url":"/issuer/0001392266","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8044.0,"shares_display":"8,044","price_per_share":1.96,"price_display":"1.96","price_state":"stated","total_value":15766.24,"total_display":"15,766.24","total_whole":"15,766","shares_owned_after":377071.0,"shares_owned_after_display":"377,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-09","scope":"insider"},{"id":4205237,"accession":"0001628280-25-016991","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-016991","line_url":"/filing/0001628280-25-016991#line-2","is_derivative":false,"issuer_cik":"0001392266","issuer_name":"OmniAb, Inc.","issuer_ticker":"OABI","issuer_name_source":null,"issuer_url":"/issuer/0001392266","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7206.0,"shares_display":"7,206","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":14412.0,"total_display":"14,412.00","total_whole":"14,412","shares_owned_after":363212.0,"shares_owned_after_display":"363,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-07","filed_date":"2025-04-07","scope":"insider"},{"id":4856543,"accession":"0001846253-25-000012","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001846253-25-000012","line_url":"/filing/0001846253-25-000012#line-4","is_derivative":false,"issuer_cik":"0001392266","issuer_name":"OmniAb, Inc.","issuer_ticker":"OABI","issuer_name_source":null,"issuer_url":"/issuer/0001392266","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7255.0,"shares_display":"7,255","price_per_share":3.67,"price_display":"3.67","price_state":"stated","total_value":26625.85,"total_display":"26,625.85","total_whole":"26,626","shares_owned_after":356876.0,"shares_owned_after_display":"356,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-19","scope":"insider"},{"id":4856533,"accession":"0001846253-25-000012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001846253-25-000012","line_url":"/filing/0001846253-25-000012#line-3","is_derivative":false,"issuer_cik":"0001392266","issuer_name":"OmniAb, Inc.","issuer_ticker":"OABI","issuer_name_source":null,"issuer_url":"/issuer/0001392266","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8215.0,"shares_display":"8,215","price_per_share":3.68,"price_display":"3.68","price_state":"stated","total_value":30231.2,"total_display":"30,231.20","total_whole":"30,231","shares_owned_after":364131.0,"shares_owned_after_display":"364,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-19","scope":"insider"},{"id":4483184,"accession":"0001846253-25-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001846253-25-000006","line_url":"/filing/0001846253-25-000006#line-2","is_derivative":false,"issuer_cik":"0001392266","issuer_name":"OmniAb, Inc.","issuer_ticker":"OABI","issuer_name_source":null,"issuer_url":"/issuer/0001392266","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25489.0,"shares_display":"25,489","price_per_share":3.24,"price_display":"3.24","price_state":"stated","total_value":82584.36,"total_display":"82,584.36","total_whole":"82,584","shares_owned_after":343190.0,"shares_owned_after_display":"343,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-22","scope":"insider"},{"id":2445851,"accession":"0001846253-24-000099","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001846253-24-000099","line_url":"/filing/0001846253-24-000099#line-2","is_derivative":false,"issuer_cik":"0001392266","issuer_name":"OmniAb, Inc.","issuer_ticker":"OABI","issuer_name_source":null,"issuer_url":"/issuer/0001392266","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8022.0,"shares_display":"8,022","price_per_share":4.13,"price_display":"4.13","price_state":"stated","total_value":33130.86,"total_display":"33,130.86","total_whole":"33,131","shares_owned_after":323385.0,"shares_owned_after_display":"323,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-09","filed_date":"2024-12-10","scope":"insider"},{"id":3274347,"accession":"0002001011-24-000044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002001011-24-000044","line_url":"/filing/0002001011-24-000044#line-2","is_derivative":false,"issuer_cik":"0001392266","issuer_name":"OmniAb, Inc.","issuer_ticker":"OABI","issuer_name_source":null,"issuer_url":"/issuer/0001392266","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6954.0,"shares_display":"6,954","price_per_share":5.27,"price_display":"5.27","price_state":"stated","total_value":36647.58,"total_display":"36,647.58","total_whole":"36,648","shares_owned_after":292617.0,"shares_owned_after_display":"292,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-08","filed_date":"2024-04-09","scope":"insider"},{"id":4253745,"accession":"0000886163-21-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-21-000030","line_url":"/filing/0000886163-21-000030#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (SVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18097.0,"shares_display":"18,097","price_per_share":178.5034,"price_display":"178.50","price_state":"stated","total_value":3230376.0298,"total_display":"3,230,376.03","total_whole":"3,230,376","shares_owned_after":28906.0,"shares_owned_after_display":"28,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-04","filed_date":"2021-02-05","scope":"insider"},{"id":2167911,"accession":"0000886163-20-000063","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-20-000063","line_url":"/filing/0000886163-20-000063#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (SVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11146.0,"shares_display":"11,146","price_per_share":118.5874,"price_display":"118.59","price_state":"stated","total_value":1321775.1604,"total_display":"1,321,775.16","total_whole":"1,321,775","shares_owned_after":40877.0,"shares_owned_after_display":"40,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-04","filed_date":"2020-06-05","scope":"insider"},{"id":6743867,"accession":"0000886163-18-000135","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-18-000135","line_url":"/filing/0000886163-18-000135#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (SVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2813.0,"shares_display":"2,813","price_per_share":250.6866,"price_display":"250.69","price_state":"stated","total_value":705181.4058,"total_display":"705,181.41","total_whole":"705,181","shares_owned_after":27763.0,"shares_owned_after_display":"27,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-17","filed_date":"2018-09-18","scope":"insider"},{"id":5977412,"accession":"0000886163-18-000132","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000886163-18-000132","line_url":"/filing/0000886163-18-000132#line-5","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (SVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19417.0,"shares_display":"19,417","price_per_share":254.9861,"price_display":"254.99","price_state":"stated","total_value":4951065.1037,"total_display":"4,951,065.10","total_whole":"4,951,065","shares_owned_after":27763.0,"shares_owned_after_display":"27,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-04","filed_date":"2018-09-05","scope":"insider"},{"id":5337974,"accession":"0000886163-17-000098","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-17-000098","line_url":"/filing/0000886163-17-000098#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (VP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (VP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18625.0,"shares_display":"18,625","price_per_share":126.9622,"price_display":"126.96","price_state":"stated","total_value":2364670.975,"total_display":"2,364,670.98","total_whole":"2,364,671","shares_owned_after":24423.0,"shares_owned_after_display":"24,423","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-09","filed_date":"2017-08-10","scope":"insider"},{"id":2861634,"accession":"0000886163-16-000211","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000886163-16-000211","line_url":"/filing/0000886163-16-000211","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (VP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (VP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22067.0,"shares_display":"22,067","price_per_share":123.16,"price_display":"123.16","price_state":"stated","total_value":2717771.72,"total_display":"2,717,771.72","total_whole":"2,717,772","shares_owned_after":29647.0,"shares_owned_after_display":"29,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-05","filed_date":"2016-08-09","scope":"insider","n_lines":3},{"id":8554754,"accession":"0000886163-15-000079","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000886163-15-000079","line_url":"/filing/0000886163-15-000079","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (VP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (VP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14067.0,"shares_display":"14,067","price_per_share":99.14053742802304,"price_display":"99.14","price_state":"stated","total_value":1394609.94,"total_display":"1,394,609.94","total_whole":"1,394,610","shares_owned_after":29279.0,"shares_owned_after_display":"29,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-10","filed_date":"2015-07-14","scope":"insider","n_lines":3},{"id":8653094,"accession":"0000886163-15-000036","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000886163-15-000036","line_url":"/filing/0000886163-15-000036","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (VP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (VP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11264.0,"shares_display":"11,264","price_per_share":74.54271306818181,"price_display":"74.54","price_state":"stated","total_value":839649.12,"total_display":"839,649.12","total_whole":"839,649","shares_owned_after":25989.0,"shares_owned_after_display":"25,989","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-16","filed_date":"2015-03-18","scope":"insider","n_lines":3},{"id":8124615,"accession":"0000886163-15-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-15-000008","line_url":"/filing/0000886163-15-000008#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (VP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (VP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":126.0,"shares_display":"126","price_per_share":45.2285,"price_display":"45.23","price_state":"stated","total_value":5698.791,"total_display":"5,698.79","total_whole":"5,699","shares_owned_after":27433.0,"shares_owned_after_display":"27,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-31","filed_date":"2015-01-05","scope":"insider"},{"id":6480564,"accession":"0000886163-14-000082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-14-000082","line_url":"/filing/0000886163-14-000082#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (VP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (VP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":329.0,"shares_display":"329","price_per_share":43.792,"price_display":"43.79","price_state":"stated","total_value":14407.568,"total_display":"14,407.57","total_whole":"14,408","shares_owned_after":27307.0,"shares_owned_after_display":"27,307","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-30","filed_date":"2014-07-01","scope":"insider"},{"id":6716917,"accession":"0000886163-14-000060","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000886163-14-000060","line_url":"/filing/0000886163-14-000060","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (VP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (VP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7166.0,"shares_display":"7,166","price_per_share":66.90394920457717,"price_display":"66.90","price_state":"stated","total_value":479433.7,"total_display":"479,433.70","total_whole":"479,434","shares_owned_after":26978.0,"shares_owned_after_display":"26,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-27","filed_date":"2014-05-28","scope":"insider","n_lines":4},{"id":7062147,"accession":"0000886163-14-000026","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000886163-14-000026","line_url":"/filing/0000886163-14-000026","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (VP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (VP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14881.0,"shares_display":"14,881","price_per_share":74.5,"price_display":"74.50","price_state":"stated","total_value":1108634.5,"total_display":"1,108,634.50","total_whole":"1,108,635","shares_owned_after":29645.0,"shares_owned_after_display":"29,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-12","filed_date":"2014-02-14","scope":"insider","n_lines":7},{"id":6890826,"accession":"0000886163-14-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-14-000003","line_url":"/filing/0000886163-14-000003#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (VP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (VP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":209.0,"shares_display":"209","price_per_share":33.915,"price_display":"33.92","price_state":"stated","total_value":7088.235,"total_display":"7,088.24","total_whole":"7,088","shares_owned_after":27145.0,"shares_owned_after_display":"27,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-31","filed_date":"2014-01-02","scope":"insider"},{"id":5380080,"accession":"0000886163-13-000088","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000886163-13-000088","line_url":"/filing/0000886163-13-000088","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (VP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (VP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28323.0,"shares_display":"28,323","price_per_share":47.5393,"price_display":"47.54","price_state":"stated","total_value":1346455.5939,"total_display":"1,346,455.59","total_whole":"1,346,456","shares_owned_after":17928.0,"shares_owned_after_display":"17,928","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-30","filed_date":"2013-09-04","scope":"insider","n_lines":3},{"id":5001704,"accession":"0000886163-13-000085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-13-000085","line_url":"/filing/0000886163-13-000085#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (VP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (VP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14583.0,"shares_display":"14,583","price_per_share":42.634,"price_display":"42.63","price_state":"stated","total_value":621731.622,"total_display":"621,731.62","total_whole":"621,732","shares_owned_after":13644.0,"shares_owned_after_display":"13,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-16","filed_date":"2013-08-20","scope":"insider"},{"id":4665902,"accession":"0000886163-13-000064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-13-000064","line_url":"/filing/0000886163-13-000064#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (VP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (VP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":815.0,"shares_display":"815","price_per_share":17.36,"price_display":"17.36","price_state":"stated","total_value":14148.4,"total_display":"14,148.40","total_whole":"14,148","shares_owned_after":13644.0,"shares_owned_after_display":"13,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-28","filed_date":"2013-07-01","scope":"insider"},{"id":5001696,"accession":"0000886163-13-000042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-13-000042","line_url":"/filing/0000886163-13-000042#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (VP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (VP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":26.66,"price_display":"26.66","price_state":"stated","total_value":106640.0,"total_display":"106,640.00","total_whole":"106,640","shares_owned_after":12829.0,"shares_owned_after_display":"12,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-10","filed_date":"2013-05-13","scope":"insider"},{"id":2938058,"accession":"0000886163-12-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-12-000051","line_url":"/filing/0000886163-12-000051#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (VP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (VP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4249.0,"shares_display":"4,249","price_per_share":18.77,"price_display":"18.77","price_state":"stated","total_value":79753.73,"total_display":"79,753.73","total_whole":"79,754","shares_owned_after":14329.0,"shares_owned_after_display":"14,329","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-07","filed_date":"2012-09-10","scope":"insider"},{"id":3149683,"accession":"0000886163-12-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-12-000023","line_url":"/filing/0000886163-12-000023","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (VP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (VP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3606.0,"shares_display":"3,606","price_per_share":15.760291070438159,"price_display":"15.76","price_state":"stated","total_value":56831.6096,"total_display":"56,831.61","total_whole":"56,832","shares_owned_after":17434.0,"shares_owned_after_display":"17,434","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-08","filed_date":"2012-03-08","scope":"insider","n_lines":2},{"id":9079198,"accession":"0000886163-11-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-11-000011","line_url":"/filing/0000886163-11-000011#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001392266","owner_name":"Berkman Charles S","owner_display_name":"Berkman Charles S","owner_url":"/insider/0001392266","role":"Officer (VP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (VP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":9.7501,"price_display":"9.75","price_state":"stated","total_value":48750.5,"total_display":"48,750.50","total_whole":"48,751","shares_owned_after":11696.0,"shares_owned_after_display":"11,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-16","filed_date":"2011-02-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":48,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":44,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":48},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001846253","name":"OmniAb, Inc.","url":"/issuer/0001846253","role":"Officer (Chief Legal Officer)","n_filings":9,"first_seen":"2024-04-09","last_seen":"2026-04-07"},{"type":"issuer","type_label":"ISSUER","cik":"0000886163","name":"LIGAND PHARMACEUTICALS INC","url":"/issuer/0000886163","role":"Officer (SVP, Gen. Counsel & Secretary)","n_filings":20,"first_seen":"2011-02-18","last_seen":"2021-02-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001392266","retrieved_at":"2026-08-25T11:55:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}